SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 5 — Focused Visit (Follow-up) — Mary Seacole

PatientMary Seacole
Date of birth1954-11-23
IdentifiersMRN HR-NI027-SYN; SSN (made up) 000-27-4483
Document date2026-06-15
AuthorAdwoa Fairweather-Kent, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Three-month review after chlorthalidone was stopped. [S]

History of Present Illness

Mary Seacole returns five weeks after the sick visit, when chlorthalidone was stopped for a low sodium. The dizziness on standing went within two days, she ate normally once the cold passed, and she has had no further near-falls. The sodium recheck planned for a week after that visit did not happen: she felt well, and the trip to the laboratory by bus with her knees seemed too much for a single blood test. On amlodipine alone her home readings average 140/82, and her ankles swell a little by evening. She has finished the physical therapy course and goes to the tai chi class twice a week. Her knees are better; she asked about an injection but would rather keep to exercise, her own massage and the gel for now. [S]

ElementDetail
Home readingsAverage 140/82 mmHg on amlodipine alone
After the sick visitDizziness gone; no near-falls; one-week sodium recheck missed
Side effectsMild ankle swelling in the evening
KneesPain 4 out of 10; tai chi twice a week

Review of Systems

SystemResultFinding
CardiovascularPositiveMild evening ankle swelling; no dizziness on standing
NeurologicalNegativeNo headaches, confusion, weakness or numbness
MusculoskeletalPositiveKnee pain 4 out of 10
PsychiatricNegativeEnjoys the tai chi group; mood better

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Diclofenac sodium 1% topical gel, 4 g rubbed into each painful knee up to four times a day4 g to each knee up to four times a dayTopical route2026-03-09activeS
Amlodipine 5 mg oral tablet, one tablet dailyOne tablet dailyOral route2026-03-16activeS
Chlorthalidone 12.5 mg oral tablet, one tablet each morningOne tablet each morningOral route2026-03-16 to 2026-05-11completedS
Atorvastatin 20 mg oral tablet, one tablet dailyOne tablet dailyOral route2026-04-13activeS
Losartan 25 mg oral tablet, one tablet dailyOne tablet dailyOral route2026-06-15activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-06-15Body height157cmS
2026-06-15Body weight77.2kgS
2026-06-15Body mass index (BMI) [Ratio]31.3kg/m2S
2026-06-15Systolic blood pressure144mm[Hg]S
2026-06-15Diastolic blood pressure84mm[Hg]S
2026-06-15Heart rate74/minS
2026-06-15Respiratory rate16/minS
2026-06-15Body temperature36.7CelS
2026-06-15Oxygen saturation in Arterial blood by Pulse oximetry97%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-06-15Sodium [Moles/volume] in Serum or Plasma138mmol/L135-145 mmol/LNormalS
2026-06-15Potassium [Moles/volume] in Serum or Plasma4.2mmol/L3.5-5.1 mmol/LNormalS
2026-06-15Creatinine [Mass/volume] in Serum or Plasma0.94mg/dL0.59-1.04 mg/dLNormalS
2026-06-15Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M65mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-06-15Glucose [Mass/volume] in Serum or Plasma95mg/dL70-99 mg/dLNormalS
2026-06-15Cholesterol [Mass/volume] in Serum or Plasma160mg/dL<=199 mg/dLNormalS
2026-06-15Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation82mg/dL<=99 mg/dLNormalS
2026-06-15Cholesterol in HDL [Mass/volume] in Serum or Plasma56mg/dL>=50 mg/dLNormalS
2026-06-15Triglyceride [Mass/volume] in Serum or Plasma110mg/dL<=149 mg/dLNormalS
2026-06-15Pain severity - 0-10 verbal numeric rating [Score] - Reported4{score}S
2026-06-15Total interval score [KOOSJR]61.6{score}S

Physical Exam

Vital signs recorded on 2026-06-15; see the Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 144/84 seated, 140/82 standing at three minutes, pulse 74; weight 77.2 kg
CardiovascularRegular rhythm; trace ankle edema
MusculoskeletalNo knee effusion; Timed Up and Go 13 seconds with the cane

Problems

ProblemClinical statusVerificationCodeProvenance
Headaches on waking for three weeks and blood pressure 184/102 mmHg at the visit (average of two seated readings with a large cuff); no chest pain, breathlessness, visual loss, confusion or weakness; fundi with arteriolar narrowing but no hemorrhages or papilledema; no hypertensive emergency; hypertension not yet confirmedresolvedprovisional R03.0S — Synthetic presenting problem; resolved into stage 2 hypertension when a week of home readings confirmed it. Not a claim about her real health.
Stage 2 hypertension confirmed by home readings (seven-day average 168/96 mmHg), with left ventricular hypertrophy by ECG voltage; no albuminuria; 10-year cardiovascular risk about 14%; treated to reduce the risk of stroke, heart failure and kidney diseaseactiveconfirmed I10S — Synthetic modern diagnosis made at the second visit. It is linked to the recorded apoplexy before her death only as the reason for the stroke-prevention teaching; the record does not claim that she had hypertension.
Bilateral primary knee osteoarthritis, worse on the left: pain on stairs and on rising from a chair, morning stiffness under 30 minutes, crepitus and bony enlargement without warmth; clinical diagnosis without imagingactiveconfirmed M17.0S — Synthetic modern problem; not a claim about her real health.
Fall risk: one fall in the past year, a trip on the outside steps without injury; afraid of falling and going out less; STEADI screen positive; Timed Up and Go 15 secondsactiveconfirmed Z91.81S — Synthetic fall-risk problem.
Obesity, class 1 (BMI 31.6); she calls herself stout and wants to lose some weight for her kneesactiveconfirmed E66.811S — Synthetic modern problem; her self-description as stout is documented, her weight is not.
Thiazide-associated hyponatremia (sodium 129 mmol/L) and hypokalemia (potassium 3.3 mmol/L) with orthostatic hypotension and a near-fall, after four days of a cold with little food while taking chlorthalidone; no confusion; resolved after chlorthalidone was stoppedresolvedconfirmed E87.1S — Synthetic adverse drug event at an unscheduled visit; a common effect of thiazide diuretics in older women, not a historical diagnosis.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationBlood pressure in the clinic (seated, large cuff, two readings) and at home; target below 130/80 mmHgEvery visitCompleted today144/84 mmHg; home average 140/82
ExaminationOrthostatic blood pressure (lying and standing)Every visitCompleted todayNo orthostatic drop
ExaminationWeight and BMI (5% weight-loss goal for knee osteoarthritis)Every visitCompleted today77.2 kg, BMI 31.3
ExaminationCardiac auscultation and edemaEvery visitCompleted todayTrace ankle edema from amlodipine
LaboratorySodium, potassium, creatinine and eGFROne week after a low sodium, then as for the medicinesDeferredThe sodium and potassium recheck due one week after the sick visit was missed: she felt well, and the bus trip to the laboratory with her knees seemed too much for one test. Today, five weeks after chlorthalidone was stopped, sodium is 138 mmol/L, potassium 4.2 and creatinine 0.94 mg/dL (eGFR 65), all normal, and she has had no symptoms, so no harm resulted. Corrective action: blood tests are drawn at home by the community nurse when a separate trip would be needed
LaboratoryLipid panelFour to twelve weeks after starting a statin, then yearlyCompleted todayNine weeks on atorvastatin 20 mg: LDL 82 mg/dL (down 44%), total cholesterol 160, HDL 56, triglycerides 110
ImagingEchocardiogramAt diagnosis if stage 2 or left ventricular hypertrophyUp to dateDone at the four-week review
SurveyKnee pain score (0 to 10)Every visitCompleted today4 out of 10
SurveyKnee function (KOOS JR)Every visitCompleted todayKOOS JR 61.6
ExaminationKnee examination (range of motion, effusion, alignment, crepitus)Every visitCompleted todayNo effusion
Self-managementExercise therapy, tai chi and self-managementOngoingCompleted todayPhysical therapy course finished; tai chi twice a week
Medication safetyNSAID safety (topical diclofenac; no oral NSAIDs)Every visitCompleted todayDiclofenac gel only; intra-articular corticosteroid offered and declined
ExaminationSTEADI assessment: Timed Up and Go, 30-second chair stand, 4-stage balanceAt diagnosis of fall risk, then yearly or with a fallCompleted todayTimed Up and Go 13 seconds; one near-fall in May with low sodium, none since
Medication safetyMedicine review for fall risk and interactions (Beers criteria)Every visitCompleted todayChlorthalidone stopped; losartan added
Self-managementHer own remedies: interactions and how she uses themEvery visitCompleted todayLiquorice still paused; ginger tea; liniment on the right knee
Self-managementLoneliness, costs and transportEvery visitCompleted todayTai chi group twice a week; lunch club starting

Goal progress:

Guideline basis: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025); 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee (2019); STEADI: Stopping Elderly Accidents, Deaths, and Injuries (2026); Falls Prevention in Community-Dwelling Older Adults: Interventions (2024); 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol (2018); American Geriatrics Society 2023 Updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults (2023); Licorice Root (2026); Ginger (2026); CMID: Clinical Monitoring Intelligence Database, hypertension, osteoarthritis and osteoporosis monographs (2026)

Follow-up: Annual wellness visit in four weeks, with potassium and creatinine. Call for dizziness, swelling of the lips or face, or a fall. Next scheduled visit 2026-07-13: subsequent annual wellness visit. [S]